123 related articles for article (PubMed ID: 28410986)
21. Predicting biopsy-proven prostate cancer recurrence following cryosurgery.
Caso JR; Tsivian M; Mouraviev V; Polascik TJ
Urol Oncol; 2012; 30(4):391-5. PubMed ID: 20826095
[TBL] [Abstract][Full Text] [Related]
22. [The correlation of PSA-nadir PS recurrence after total HIFU-ablation in patients with localized prostate cancer].
Fomkin RN; Krupinov GE; Churakov AA; Shatylko TV; Fomkina OA; Zhmakin VA
Urologiia; 2020 Sep; (4):79-83. PubMed ID: 32897659
[TBL] [Abstract][Full Text] [Related]
23. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
Ganzer R; Robertson CN; Ward JF; Brown SC; Conti GN; Murat FJ; Pasticier G; Rebillard X; Thuroff S; Wieland WF; Blana A
BJU Int; 2011 Oct; 108(8 Pt 2):E196-201. PubMed ID: 21332907
[TBL] [Abstract][Full Text] [Related]
24. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
25. Oncological outcomes of cryosurgery as primary treatment in T3 prostate cancer: experience of a single centre.
Guo Z; Si T; Yang X; Xu Y
BJU Int; 2015 Jul; 116(1):79-84. PubMed ID: 25168692
[TBL] [Abstract][Full Text] [Related]
26. Focal Therapy for Localized Prostate Cancer with Either High Intensity Focused Ultrasound or Cryoablation: A Single Institution Experience.
Tourinho-Barbosa RR; Sanchez-Salas R; Claros OR; Collura-Merlier S; Bakavicius A; Carneiro A; Stabile A; Moschini M; Cathala N; Tobias-Machado M; Cathelineau X
J Urol; 2020 Feb; 203(2):320-330. PubMed ID: 31437121
[TBL] [Abstract][Full Text] [Related]
27. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
[TBL] [Abstract][Full Text] [Related]
28. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
[TBL] [Abstract][Full Text] [Related]
29. Seven years of experience with high-intensity focused ultrasound for prostate cancer: advantages and limitations.
Sung HH; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
Prostate; 2012 Sep; 72(13):1399-406. PubMed ID: 22253052
[TBL] [Abstract][Full Text] [Related]
30. Prediction of biochemical recurrence after radical prostatectomy using peritumoral lymphatic vessel density in biopsy specimens in patients with localized prostate cancer.
Kuroda K; Horiguchi A; Asano T; Tasaki S; Yoshii H; Sato A; Asakuma J; Ito K; Seguchi K; Sumitomo M; Asano T
Urol Int; 2012; 88(1):18-24. PubMed ID: 22222198
[TBL] [Abstract][Full Text] [Related]
31. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
32. Primary cryosurgery for clinically localized prostate cancer--do perioperative tumor characteristics correlate with post-treatment biopsy results?
Sverrisson EF; Nguyen H; Kim T; Pow-Sang JM
Urology; 2014 Feb; 83(2):376-8. PubMed ID: 24315311
[TBL] [Abstract][Full Text] [Related]
33. Implications of greater short-term PSA recurrence with laparoscopic as compared to retropubic radical prostatectomy for Japanese clinically localized prostate carcinomas.
Akita H; Okamura T; Ando R; Nagata D; Naruyama H; Yamada Y; Naiki T; Yasui T; Tozawa K; Kohri K
Asian Pac J Cancer Prev; 2011; 12(11):2959-61. PubMed ID: 22393971
[TBL] [Abstract][Full Text] [Related]
34. Favorable risk factors in patients with positive surgical margin after robot-assisted radical prostatectomy.
Ha YS; Kang DI; Kim JH; Joung JY; Yu J; Parihar JS; Salmasi AH; Horie S; Kim WJ; Yi Kim I
Can J Urol; 2014 Jun; 21(3):7290-7. PubMed ID: 24978359
[TBL] [Abstract][Full Text] [Related]
35. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
36. Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer.
Aoun F; Albisinni S; Biaou I; Peltier A; Limani K; Roumeguère T; van Velthoven R
Prog Urol; 2019 Oct; 29(12):627-633. PubMed ID: 31400963
[TBL] [Abstract][Full Text] [Related]
37. Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years.
Suardi N; Ficarra V; Willemsen P; De Wil P; Gallina A; De Naeyer G; Schatteman P; Montorsi F; Carpentier P; Mottrie A
Urology; 2012 Jan; 79(1):133-8. PubMed ID: 22088567
[TBL] [Abstract][Full Text] [Related]
38. Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study.
Lughezzani G; Lazzeri M; Buffi NM; Abrate A; Mistretta FA; Hurle R; Pasini L; Castaldo L; Zandegiacomo De Zorzi S; Peschechera R; Fiorini G; Taverna G; Casale P; Guazzoni G
Urol Oncol; 2015 Aug; 33(8):337.e7-14. PubMed ID: 26055430
[TBL] [Abstract][Full Text] [Related]
39. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
40. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
Ritch CR; You C; May AT; Herrell SD; Clark PE; Penson DF; Chang SS; Cookson MS; Smith JA; Barocas DA
Urology; 2014 Jun; 83(6):1309-15. PubMed ID: 24746665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
